The TALISMAN clinical research study
Learn about this study for multiple myeloma that has returned or did not respond to previous treatment.
This study is for adults who have been diagnosed with multiple myeloma that has returned or did not respond to previous treatment.
You can join the study if you
- Are 18 years of age or older
- Have been diagnosed with multiple myeloma that has returned or did not respond to treatment
- Have received prior treatment for multiple myeloma
- The study doctor/staff will talk with you more about this
- The study doctor/staff will talk with you more about this
Additional eligibility criteria will apply.
You cannot join the study if you:
- Have a severely altered sense of taste
- Have had a stroke, transient ischemic attack, or seizure in the last 6 months
- Have had major surgery or a significant traumatic injury within the last 2 weeks
Additional eligibility criteria will apply.
You will receive either:
• Injections of the investigational medication + an investigational prophylactic medication, OR
• Injections of the investigational medication alone
Investigational medication injections will be given every 2 weeks during recurring 28-day cycles. If you receive an investigational prophylactic medication, you will use it or take it by mouth twice a day.
The investigational prophylactic medication you receive could be a mouthwash, pill, or disintegrating tablet.
Your total study participation may last up to approximately 2.5 years. During this time, you will have regularly scheduled study clinic visits for health exams and tests.
Research studies allow doctors and researchers to evaluate an investigational medication. When you participate in a research study, you may help them learn more about the safety and efficacy of an investigational medication.
Without your participation, advancements in research for conditions like multiple myeloma would not be possible.
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind: Even if you believe you meet the eligibility criteria, joining a clinical research study is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional. This questionnaire is intended for United States participants only.
Note about privacy: Email responses may not be encrypted. This means there’s a chance the messages could be seen by someone other than the intended recipient. We will avoid including sensitive personal information in emails whenever possible. However, we cannot guarantee that no sensitive information will be revealed indirectly.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.